Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
SpringWorks Therapeutics logo — company profile

SpringWorks Therapeutics

Founded 2017 United States Stamford, United States 372 employees Post Ipo Equity Total: $1.02B Biopharma, Biotechnology +1

General Information

Company Name SpringWorks Therapeutics
Founded Year 2017
Location United States Stamford, United States +2
Founders / Decision Makers
Team member Team member
Employees 372
Industries Biopharma, Biotechnology, Health and Wellness
Funding Stage Post Ipo Equity
Social

Get notified when SpringWorks Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About SpringWorks Therapeutics

SpringWorks Therapeutics is a commercial-stage biopharmaceutical company that utilizes a precision medicine approach to develop and deliver life-changing medicines for individuals grappling with severe rare diseases and cancer. Founded in 2017, the company boasts a diversified targeted oncology pipeline spanning solid tumors and hematological cancers. This pipeline includes clinical trials in rare tumor types and highly prevalent, genetically defined cancers. Headquartered in the United States, SpringWorks recently received a substantial $275.00 million in Post-IPO Equity investment on 05 December 2023, showing promising growth potential and attracting interest from investors.

Taxonomy: biopharmaceutical, precision medicine, rare diseases, cancer, oncology, pipeline, clinical trials, targeted therapy, genetically defined cancers

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 05 Dec 2023
Post-IPO Equity •••••• 5
Investor Investor Investor
•••• •••• 		07 Sep 2022
Post-IPO Equity •••••• - 07 Oct 2020
Series B •••••• 5
Investor Investor Investor Investor
•••• •••• 		01 Apr 2019
Series A •••••• - 25 Sep 2017

SpringWorks Therapeutics Alternatives & Competitors

SpringWorks Therapeutics vs
Springworks AB
Springworks AB Sweden

Spark a conversation with your car. Connecting all car owners with the service they deserve, through...

Convertible Note
10 employees
Internet, IoT
Compare SpringWorks Therapeutics vs Springworks AB
SpringWorks Therapeutics vs
Dysplasia Diagnostics Limited
Dysplasia Diagnostics Limited United Kingdom

We are developing non-invasive screening methods to detect cancer early and save lives.

4 employees
SpringWorks Therapeutics vs
RareCan
RareCan United Kingdom

RareCan aims to accelerate research and ultimately improve treatments and outcomes for people with r...

Equity Crowdfunding
8 employees
Biotechnology, Health Care
Compare SpringWorks Therapeutics vs RareCan
Also compare with: SpringWorks Therapeutics vs Rare Cancers Australia Rare Cancers Australia SpringWorks Therapeutics vs Ayala Pharmaceuticals Ayala Pharmaceuticals

FAQ About SpringWorks Therapeutics

SpringWorks is a commercial-stage biopharmaceutical company applying a precision medicine approach to developing and delivering life-changing medicines for people with severe rare diseases and cancer. Founded in 2017, SpringWorks has a diversified targeted oncology pipeline spanning solid tumors an...
SpringWorks Therapeutics was founded in 2017.
SpringWorks Therapeutics is headquartered in Stamford, United States.
SpringWorks Therapeutics operates in the following industries: Biopharma, Biotechnology, Health and Wellness.
SpringWorks Therapeutics has approximately 372 employees.
SpringWorks Therapeutics has completed 5 funding rounds, raising a total of $1.02B. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to SpringWorks Therapeutics include Springworks AB, Dysplasia Diagnostics Limited, RareCan, Rare Cancers Australia, Plus Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SpringWorks Therapeutics and Springworks AB are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors SpringWorks Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy